Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicure (MCUJF) Research & Development (2016 - 2025)

Historic Research & Development for Medicure (MCUJF) over the last 17 years, with Q3 2025 value amounting to $520868.2.

  • Medicure's Research & Development fell 1062.31% to $520868.2 in Q3 2025 from the same period last year, while for Sep 2025 it was -$942323.2, marking a year-over-year decrease of 18174.57%. This contributed to the annual value of $2.2 million for FY2024, which is 2479.72% up from last year.
  • As of Q3 2025, Medicure's Research & Development stood at $520868.2, which was down 1062.31% from -$534789.0 recorded in Q2 2025.
  • Medicure's 5-year Research & Development high stood at $1.0 million for Q2 2022, and its period low was -$567998.0 during Q4 2022.
  • Over the past 5 years, Medicure's median Research & Development value was $371783.6 (recorded in 2021), while the average stood at $138807.4.
  • Per our database at Business Quant, Medicure's Research & Development skyrocketed by 71147.85% in 2021 and then tumbled by 180466.96% in 2022.
  • Quarter analysis of 5 years shows Medicure's Research & Development stood at $33320.1 in 2021, then plummeted by 1804.67% to -$567998.0 in 2022, then rose by 0.29% to -$566326.8 in 2023, then rose by 6.21% to -$531160.1 in 2024, then skyrocketed by 198.06% to $520868.2 in 2025.
  • Its last three reported values are $520868.2 in Q3 2025, -$534789.0 for Q2 2025, and -$397242.4 during Q1 2025.